Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial
Monique C. Minnema, Kazem Nasserinejad, Bouke Hazenberg, Ute Hegenbart, Philip Vlummens, Paula F. Ypma, Nicolaus Kröger, Ka Lung Wu, Marie Jose Kersten, M. Ron Schaafsma, Sandra Croockewit, Esther de Waal, Sonja Zweegman, Lidwien Tick, Annemieke Broijl, Harry Koene, Gerard Bos, Pieter Sonneveld, Stefan Schönland
Haematologica November 2019 104: 2274-2282; doi:10.3324/haematol.2018.213900
Monique C. Minnema
Department of Hematology, UMC Utrecht Cancer Center, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.c.minnema@umcutrecht.nl
Kazem Nasserinejad
HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bouke Hazenberg
Department of Rheumatology & Clinical Immunology, University of Groningen Medical Center, Groningen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ute Hegenbart
Department of Hematology, Oncology and Rheumatology, Heidelberg University, Amyloidosis Center, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Vlummens
Department of Haematology, Ghent University, Gent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula F. Ypma
Department of Hematology, HagaZiekenhuis, Den Haag, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolaus Kröger
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ka Lung Wu
Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Jose Kersten
Department of Hematology, Academic Medical Center, Lymphoma and Myeloma Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ron Schaafsma
Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Croockewit
Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther de Waal
Department of Hematology, University of Groningen, Medical Center, Groningen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonja Zweegman
Department of Hematology, VU University Medical Center, Amsterdam Cancer Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lidwien Tick
Department of Internal Medicine, Maxima Medisch Centrum, Eindhoven, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemieke Broijl
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry Koene
Department of Hematology, St. Antonius Hospital, Nieuwegein, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard Bos
Department of Hematology, Maastricht University Medical Center, Maastricht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pieter Sonneveld
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Schönland
Department of Hematology, Oncology and Rheumatology, Heidelberg University, Amyloidosis Center, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Monique C. Minnema1⇑,
  2. Kazem Nasserinejad2,
  3. Bouke Hazenberg3,
  4. Ute Hegenbart4,
  5. Philip Vlummens5,
  6. Paula F. Ypma6,
  7. Nicolaus Kröger7,
  8. Ka Lung Wu8,
  9. Marie Jose Kersten9,
  10. M. Ron Schaafsma10,
  11. Sandra Croockewit11,
  12. Esther de Waal12,
  13. Sonja Zweegman13,
  14. Lidwien Tick14,
  15. Annemieke Broijl15,
  16. Harry Koene16,
  17. Gerard Bos17,
  18. Pieter Sonneveld15 and
  19. Stefan Schönland4
  1. 1Department of Hematology, UMC Utrecht Cancer Center, Utrecht, the Netherlands
  2. 2HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  3. 3Department of Rheumatology & Clinical Immunology, University of Groningen Medical Center, Groningen, the Netherlands
  4. 4Department of Hematology, Oncology and Rheumatology, Heidelberg University, Amyloidosis Center, Heidelberg, Germany
  5. 5Department of Haematology, Ghent University, Gent, Belgium
  6. 6Department of Hematology, HagaZiekenhuis, Den Haag, the Netherlands
  7. 7Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  8. 8Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium
  9. 9Department of Hematology, Academic Medical Center, Lymphoma and Myeloma Center, Amsterdam, the Netherlands
  10. 10Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands
  11. 11Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
  12. 12Department of Hematology, University of Groningen, Medical Center, Groningen, the Netherlands
  13. 13Department of Hematology, VU University Medical Center, Amsterdam Cancer Center, Amsterdam, the Netherlands
  14. 14Department of Internal Medicine, Maxima Medisch Centrum, Eindhoven, the Netherlands
  15. 15Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  16. 16Department of Hematology, St. Antonius Hospital, Nieuwegein, the Netherlands
  17. 17Department of Hematology, Maastricht University Medical Center, Maastricht, the Netherlands
  1. Correspondence:
    MONIQUE C. MINNEMA m.c.minnema{at}umcutrecht.nl
View Abstract
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 104 no. 11 2274-2282
DOI 
https://doi.org/10.3324/haematol.2018.213900
PubMed 
30923094

Published By 
Haematologica
Print ISSN 
0390-6078
Online ISSN 
1592-8721

History 
  • Received December 6, 2018
  • Accepted March 18, 2019
  • .

Article Versions

  • previous version (March 28, 2019 - 02:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright© 2019 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

Author Information

  1. Monique C. Minnema1⇑,
  2. Kazem Nasserinejad2,
  3. Bouke Hazenberg3,
  4. Ute Hegenbart4,
  5. Philip Vlummens5,
  6. Paula F. Ypma6,
  7. Nicolaus Kröger7,
  8. Ka Lung Wu8,
  9. Marie Jose Kersten9,
  10. M. Ron Schaafsma10,
  11. Sandra Croockewit11,
  12. Esther de Waal12,
  13. Sonja Zweegman13,
  14. Lidwien Tick14,
  15. Annemieke Broijl15,
  16. Harry Koene16,
  17. Gerard Bos17,
  18. Pieter Sonneveld15 and
  19. Stefan Schönland4
  1. 1Department of Hematology, UMC Utrecht Cancer Center, Utrecht, the Netherlands
  2. 2HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  3. 3Department of Rheumatology & Clinical Immunology, University of Groningen Medical Center, Groningen, the Netherlands
  4. 4Department of Hematology, Oncology and Rheumatology, Heidelberg University, Amyloidosis Center, Heidelberg, Germany
  5. 5Department of Haematology, Ghent University, Gent, Belgium
  6. 6Department of Hematology, HagaZiekenhuis, Den Haag, the Netherlands
  7. 7Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  8. 8Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium
  9. 9Department of Hematology, Academic Medical Center, Lymphoma and Myeloma Center, Amsterdam, the Netherlands
  10. 10Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands
  11. 11Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands
  12. 12Department of Hematology, University of Groningen, Medical Center, Groningen, the Netherlands
  13. 13Department of Hematology, VU University Medical Center, Amsterdam Cancer Center, Amsterdam, the Netherlands
  14. 14Department of Internal Medicine, Maxima Medisch Centrum, Eindhoven, the Netherlands
  15. 15Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
  16. 16Department of Hematology, St. Antonius Hospital, Nieuwegein, the Netherlands
  17. 17Department of Hematology, Maastricht University Medical Center, Maastricht, the Netherlands
  1. Correspondence:
    MONIQUE C. MINNEMA m.c.minnema{at}umcutrecht.nl
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: March 2019 to November 2019

AbstractFullPdf
Mar 201955025
Apr 20196470174
May 201994059
Jun 201951028
Jul 201937016
Aug 201941015
Sep 201945035
Oct 20191111657
Nov 2019184210111
PreviousNext
Back to top

Vol 104 Issue 11

Haematologica: 104 (11)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Print
Citation Tools
Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial
Monique C. Minnema, Kazem Nasserinejad, Bouke Hazenberg, Ute Hegenbart, Philip Vlummens, Paula F. Ypma, Nicolaus Kröger, Ka Lung Wu, Marie Jose Kersten, M. Ron Schaafsma, Sandra Croockewit, Esther de Waal, Sonja Zweegman, Lidwien Tick, Annemieke Broijl, Harry Koene, Gerard Bos, Pieter Sonneveld, Stefan Schönland
Haematologica Nov 2019, 104 (11) 2274-2282; DOI: 10.3324/haematol.2018.213900

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Monique C. Minnema, Kazem Nasserinejad, Bouke Hazenberg, Ute Hegenbart, Philip Vlummens, Paula F. Ypma, Nicolaus Kröger, Ka Lung Wu, Marie Jose Kersten, M. Ron Schaafsma, Sandra Croockewit, Esther de Waal, Sonja Zweegman, Lidwien Tick, Annemieke Broijl, Harry Koene, Gerard Bos, Pieter Sonneveld, Stefan Schönland
Haematologica Nov 2019, 104 (11) 2274-2282; DOI: 10.3324/haematol.2018.213900
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Request Permissions
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

More in this TOC Section

Article

  • Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples
  • Clonal hematopoiesis and risk of acute myeloid leukemia
  • Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
Show more Article

Plasma Cell Disorders

  • Fractures and survival in multiple myeloma: results from a population-based study
  • Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma
  • Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples
Show more Plasma Cell Disorders

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online